Health and Pharmaceuticals Committee

Formed in 2002
Committee Position Paper 2021
Position Paper 2021


Yana Kotukhova SERVIER


Polina Ogorodnikova

Upcoming events

Дата ближайшего заседания пока не запланирована

If you are AEB member, Log in to register for the committee meeting or contact the Committee coordinator

  • To coordinate and protect the interests of AEB Member Companies working in health and pharmaceuticals.
Action Plan
  • To coordinate activities with the Association of International Pharmaceutical Manufacturers (AIPM)
  • To lobby for improvement in licensing and certification procedures
  • Meetings with officials from the Ministry of Health and the State Customs Committee
  • To focus on the following issues: to impact trends in the future development following recent changes in certification procedures and the implementation of the new Customs Code
  • To address intellectual property issues
  • To combat counterfeiting
  • To address brand protection issues
  • To address unfair competition
Committee news
AEB reprsentatives discussed the pharma market issues with Timofey Nizhegorodtsev, FAS
AEB Health & Pharmaceuticals Committee co-organised the Round Table on the future of digital technology in medicine and pharmaceuticals at the XII Northern Dimension Forum
AEB representatives held a meeting with the State Duma’s Deputy, member of the Duma’s Committee for Healthcare Alexander Petrov
AEB representatives took part in the VI international Conference "Antimonopoly Policy: Science, Practice, Education"
Health & Pharmaceuticals Committee members held a round table on healthcare issues at the Northern Dimension Online Forum
AEB members discussed the regulation of medical devices market with the Deputy Head of FAS Timofey Nizhegorodtsev
Tadzio Schilling spoke at the EU-Russia Health Conference "Designing Tomorrow´s Healthcare Systems"
AEB Health and Pharmaceuticals Committee met with the Director of the State Institute of Drugs and Good Practices
AEB welcomes its new Committee/Working Group Chairs!
AEB Health and Pharmaceuticals Committee met with the representatives of the Federal Antimonopoly Service (FAS)
Sub-committees and working groups
 Code of Good Practice Recommendations on OTC Drug Advertising


Back to the list